Best Biotech Stocks to Buy Now (2025)Top biotech stocks in 2025 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +32.52% per year, and are the best biotech stocks to buy now. Learn More.
Industry: Biotechnology
F
Biotech is Zen Rated F and is the 134th ranked industry out of 145 stock market industries
Learn how the Zen Ratings work| Ticker | Company | Price | 1d % | 1w % | 1m % | 3m % | 6m % | 1y % | 3y % | 5y % | 10y % | 52-week High | 52-week Low | % off 52-week High | % off 52-week Low | Beta | Volume | Vol 1d % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CDIO | CARDIO DIAGNOSTICS HOLDINGS INC | $3.23 | 14.54% | -8.24% | 26.17% | -19.05% | -12.94% | -89.44% | -89.44% | N/A | N/A | $31.80 | $2.42 | 89.84% | 33.25% | 0.97 | 24,700 | 77.70% |
| CURX | CURANEX PHARMACEUTICALS INC | $0.38 | -5.06% | -17.40% | -14.97% | -68.49% | N/A | N/A | N/A | N/A | N/A | $9.18 | $0.38 | 95.92% | 0.00% | 2.56 | 91,000 | 31.88% |
| CANF | CAN-FITE BIOPHARMA LTD | $0.25 | 0.00% | -11.66% | -24.24% | -61.54% | -76.42% | -82.64% | -96.21% | -98.63% | -99.95% | $2.33 | $0.25 | 89.27% | 2.04% | 0.57 | 730,000 | -56.16% |
| BIVI | BIOVIE INC | $1.41 | -2.76% | -2.76% | 2.92% | -24.19% | -86.31% | -93.22% | -99.86% | -99.90% | N/A | $25.76 | $1.25 | 94.53% | 12.80% | 1.59 | 48,000 | 10.34% |
| DRMA | DERMATA THERAPEUTICS INC | $2.14 | -1.83% | -18.63% | -12.30% | -60.59% | -68.34% | -79.62% | -99.61% | N/A | N/A | $23.70 | $2.13 | 90.97% | 0.47% | 0.59 | 42,700 | 54.15% |
| ENTX | ENTERA BIO LTD | $1.77 | -8.76% | -18.06% | -33.21% | -1.67% | -10.61% | -18.06% | 164.18% | 66.98% | N/A | $3.22 | $1.50 | 45.03% | 17.92% | 0.62 | 269,000 | 748.58% |
| COCP | COCRYSTAL PHARMA INC | $0.99 | -1.00% | -5.71% | 0.00% | -25.56% | -33.56% | -52.86% | -53.06% | -95.09% | N/A | $3.26 | $0.90 | 69.63% | 10.00% | 0.68 | 49,000 | -12.50% |
| CELU | CELULARITY INC | $1.45 | 16.00% | -9.38% | -14.20% | -34.68% | -17.61% | -34.83% | -88.67% | -98.73% | N/A | $4.35 | $1.00 | 66.67% | 44.86% | 1.27 | 116,000 | 38.10% |
| EVGN | EVOGENE LTD | $1.02 | 3.24% | -5.56% | -12.82% | -13.78% | -30.14% | -20.93% | -84.54% | -97.43% | -98.47% | $2.42 | $0.95 | 57.85% | 7.37% | 1.00 | 49,000 | -41.67% |
| CASI | CASI PHARMACEUTICALS INC | $0.81 | -2.64% | -6.14% | -32.50% | -54.49% | -38.87% | -69.89% | -52.91% | -97.22% | -91.82% | $3.47 | $0.80 | 76.66% | 1.12% | 0.83 | 8,300 | -29.06% |
| AZTR | AZITRA INC | $0.29 | 3.16% | -14.78% | -10.91% | -61.16% | -82.13% | -88.83% | N/A | N/A | N/A | $4.33 | $0.28 | 93.21% | 5.76% | 0.93 | 613,000 | 83.53% |
| CDTX | CIDARA THERAPEUTICS INC | $220.80 | 0.20% | 0.07% | 0.81% | 221.35% | 950.43% | 880.90% | 2,192.83% | 452.00% | -35.06% | $221.20 | $15.22 | 0.18% | 1,350.72% | 0.78 | 1,882,000 | 21.65% |
| ENLV | ENLIVEX THERAPEUTICS LTD | $0.84 | 0.36% | -10.12% | -11.08% | -20.10% | -23.39% | -29.24% | -78.31% | -92.33% | -99.53% | $2.10 | $0.79 | 60.24% | 5.16% | 0.86 | 575,000 | 17.11% |
| BYSI | BEYONDSPRING INC | $2.35 | 25.67% | 11.37% | 20.51% | 22.40% | -25.87% | 51.61% | -9.96% | -79.31% | N/A | $3.44 | $0.98 | 31.69% | 139.80% | 0.87 | 861,000 | 533.09% |
| APLT | APPLIED THERAPEUTICS INC | $0.13 | 0.81% | 6.84% | -56.14% | -71.26% | -63.56% | -87.75% | -85.24% | -99.46% | N/A | $1.50 | $0.10 | 91.67% | 25.00% | 1.19 | 5,573,000 | 13.76% |
| BOLD | BOUNDLESS BIO INC | $1.22 | -3.94% | 4.27% | 6.09% | 7.02% | 17.31% | -51.59% | N/A | N/A | N/A | $3.12 | $1.00 | 60.90% | 22.00% | 1.29 | 89,000 | -82.34% |
| IKT | INHIBIKASE THERAPEUTICS INC | $1.72 | 2.99% | 11.69% | 10.26% | 4.88% | 3.61% | -45.57% | -44.35% | -97.10% | N/A | $3.49 | $1.33 | 50.72% | 29.32% | 0.96 | 742,000 | 69.79% |
Biotech Stocks FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.